Autoimmune Diseases  >>  BMS-817399  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BMS-817399 / BMS
NCT01404585 / 2011-002024-40: Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis

Checkmark EULAR 2014: Rheumatoid Arthritis
May 2014 - May 2014: EULAR 2014: Rheumatoid Arthritis
Completed
2
123
US, Europe, RoW
Placebo, BMS-817399
Bristol-Myers Squibb
Rheumatoid Arthritis
02/13
02/13

Download Options